Medical Frontier: Breakthroughs from Chinese Hospitals

Medical Frontiers

Breakthroughs, new diagnostics and complex procedures reported by Chinese hospitals.

All stories International patient stories (11) Oncology (35) Neurology & neurosurgery (26) Cardiology & heart surgery (14) Rare & hard-to-treat diseases (48) Orthopedics & sports medicine (3) Endocrine (1) Infectious disease (1) ENT & hearing (1) Organ failure & transplant (6) Rheumatology & immunology (1) Eye (2)

5 stories

A Lifeline Across the Ocean: An American Patient with Advanced Cancer Travels from Los Angeles to Shenzhen for Treatment

Video

OncologyInternational patient story2026-10-27

A Lifeline Across the Ocean: An American Patient with Advanced Cancer Travels from Los Angeles to Shenzhen for Treatment

Larry Black of Los Angeles (with his wife Jamie) had advanced gastroesophageal-junction adenocarcinoma with peritoneal metastasis that progressed through multiple lines of therapy; 99% of tumor cells were Claudin18.2 2+/3+. After China's NMPA approved the world's first solid-tumor CAR-T (satri-cel, Claudin18.2-targeted) in June 2026, the couple travelled to the International Medical Center of HKU-Shenzhen Hospital. Prof. Pan Hongming's team infused the CAR-T cells on 29 Sep 2026; after cytokine release syndrome was managed with tocilizumab, CA19-9 fell from 8,200 to 57.6 U/mL with marked tumor shrinkage and near-complete remission, and he was discharged.

The University of Hong Kong-Shenzhen Hospital (International Medical Center)

OncologyInternational patient story2026-10-13

Across 10,000 km for a Chance at Life: Hangzhou Completes Its First Solid-Tumor CAR-T Treatment for an Overseas Chinese-American Gastric Cancer Patient

The team of Zheng Yu at Sir Run Run Shaw Hospital used the world's first approved solid-tumor CAR-T (satri-cel, CLDN18.2-targeted) to treat a Chinese-American advanced gastric cancer patient whose multi-line treatment in the US had failed — Zhejiang's first such case.

Sir Run Run Shaw Hospital

OncologyInternational patient story2026-10-28

Jiahui International Hospital Launches Cell Therapy Center for Global CAR-T Access

Jiahui International Hospital opened its International Cell Therapy Center on October 28, 2026, to expand access to CAR-T therapies for patients from China and abroad.

Jiahui International Hospital

Jiahui International Cancer Center Achieves Multiple Breakthroughs in Cell Therapy

Video

OncologyInternational patient story2026-10-28

Jiahui International Cancer Center Achieves Multiple Breakthroughs in Cell Therapy

Jiahui International Cancer Center has conducted solid tumor CAR-T treatments and served international patients while accumulating clinical experience in CAR-T for diffuse large B-cell lymphoma. The center promotes international exchange of Chinese cell therapies and was among the first to apply the world's first approved solid tumor CAR-T clinically.

Jiahui International Cancer Center

HKU-Shenzhen Hospital Successfully Applies World's First Approved Solid Tumor CAR-T Therapy

Video

OncologyInternational patient story2026-06-26

HKU-Shenzhen Hospital Successfully Applies World's First Approved Solid Tumor CAR-T Therapy

HKU-Shenzhen Hospital applied the world's first approved solid tumor CAR-T therapy to an American patient with advanced gastroesophageal junction adenocarcinoma, resulting in significantly reduced tumor markers and near complete remission. Approved by China's NMPA, it provides a breakthrough option for solid tumor patients.

The University of Hong Kong-Shenzhen Hospital